Skip to Main Content

Paper Details

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.
Cell Rep Med
369
2021
CD4, CD4+, CD4+ T cells, CD4+ and CD8+ T cells, CD8, CD8+, CD8+ T cells, COVID-19, HLA, HLA class I, HLA class I alleles, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2-specific CD4+, T cell, T cells, alleles, coronavirus disease 2019, human, human leukocyte antigen, virus
Author NameAffiliation
John SidneyCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Elizabeth J PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University
Jason A GreenbaumCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Bjoern PetersUniversity of California, San Diego (university of california san diego)
Bjoern PetersCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Bjoern PetersUniversity of California, San Diego (university of california san diego)
Davey M SmithUniversity of California, San Diego (university of california san diego)
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Alessandro SetteUniversity of California, San Diego (university of california san diego)
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)
Alessandro SetteUniversity of California, San Diego (university of california san diego)
  • 1 - 12

Datasets